FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
09-27-2018, 09:16 AM | #1 | |||
|
||||
Grand Magnate
|
Medicinova (MNOV) Reports Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ibudilast) in ALS
Medicinova (MNOV) Reports Positive FDA Feedback Regarding Phase 3 Plan for MN-166 (ibudilast) in ALS ibudilast to phase III study. Full scale phase III studies tend to be the most expensive and the final testing phase before marketing. IF they pass. |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Help for those with serious OFF periods - Positive Phase 3 Results for CVT-301 | Parkinson's Disease | |||
AB Science Reports Positive Interim Results in Phase 3 Trial of Masitinib as an ALS | ALS News & Research | |||
SYN115 Phase IIa; positive data | Parkinson's Disease | |||
new member looking for positive feedback | New Member Introductions |